2025
Common Cryoneurolysis Targets in Pain Management: Indications, Critical Anatomy, and Potential Complications
Sailer A, Latich I, Levey A. Common Cryoneurolysis Targets in Pain Management: Indications, Critical Anatomy, and Potential Complications. Seminars In Interventional Radiology 2025, 42: 205-212. PMCID: PMC12077947, DOI: 10.1055/s-0045-1804492.Peer-Reviewed Original ResearchQuality of lifePain managementCombination of therapiesImprove quality of lifeIncreased healthcare costsOpioid consumptionAdjunctive therapyHealthcare costsPatient's painUncontrolled painPhysical sufferingPainPotential complicationsAnatomical considerationsCryoneurolysisAbstract PainImprove qualityPatient outcomesPatientsClinical settingPerson's abilityCritical anatomyPatient pathologyTherapyPersonsPalliative care in acute care surgery: research challenges and opportunities
Maiga A, Ho V, Morris R, Kodadek L, Puzio T, Tominaga G, Tabata-Kelly M, Cooper Z. Palliative care in acute care surgery: research challenges and opportunities. Trauma Surgery & Acute Care Open 2025, 10: e001615. PMID: 40124208, PMCID: PMC11927415, DOI: 10.1136/tsaco-2024-001615.Peer-Reviewed Original ResearchAcute care surgeryPalliative care researchPalliative careCare researchEnd-of-life carePractice palliative carePalliative care interventionsPrimary palliative careSpecialty palliative careLife-prolonging careEnd-of-lifeRelief of sufferingQuality of lifeHigh-quality researchCare interventionsSymptom managementAdministrative dataAcute care surgeonsCareEmergency surgical conditionsSurgical illnessPrimary data collectionEffective communicationNarrative reviewCritical surgical illnessDevelopment and evaluation of a healthcare decision-making intervention for African American parent-adult daughter dementia dyads: a mixed-methods study protocol
Johnson K, Lyons K, Epps F, Daniel G, Monin J, Powell W, Hepburn K. Development and evaluation of a healthcare decision-making intervention for African American parent-adult daughter dementia dyads: a mixed-methods study protocol. BMJ Open 2025, 15: e099976. PMID: 40081986, PMCID: PMC11906994, DOI: 10.1136/bmjopen-2025-099976.Peer-Reviewed Original ResearchConceptsQuality of lifeDementia dyadsPrototype interventionQualitative data collectionQuantitative data collectionOlder adultsMixed-methods study protocolNon-Hispanic White older adultsAfrican American older adultsSelf-efficacyPretest-post-test designWhite older adultsAmerican older adultsDecision-making interventionsHealth-related decisionsSequential mixed-methods designUniversity Institutional Review BoardPrevalence of Alzheimer's diseaseAfrican American personsData collectionExplanatory sequential mixed-methods designMixed-methods designRandomised controlled trialsCare partnersIntervention MappingRetinal thickness: A window into cognitive impairment in bipolar disorder
Chart-Pascual J, Cano-Escalera G, Graña M, Zorrilla I, Lopez-Peña P, Requena C, Ceballos A, Landaluce I, Urcola H, Alvarez-Mon M, Blumberg H, Radua J, Gonzalez-Pinto A. Retinal thickness: A window into cognitive impairment in bipolar disorder. Spanish Journal Of Psychiatry And Mental Health 2025 PMID: 40081818, DOI: 10.1016/j.sjpmh.2025.01.001.Peer-Reviewed Original ResearchRetinal nerve fiber layerMacular ganglion cell layerGanglion cell layerOptical coherence tomographyInner plexiform layerBipolar disorderCoherence tomographyPeripapillary retinal nerve fiber layerNerve fiber layerMeasure retinal thicknessCognitive impairmentMarker of BDAssociated with CIPeripapillary RNFLRetinal thicknessRetinal thinningRetinal changesFiber layerHealthy controlsAssociated with worse cognitive performanceQuality of lifePlexiform layerBiological markersFunctional deficitsThickness alterationsNicotine e-cigarettes for smoking cessation: a clinical pharmacology perspective
Ameral V, Sofuoglu M, Kelly M. Nicotine e-cigarettes for smoking cessation: a clinical pharmacology perspective. Expert Review Of Clinical Pharmacology 2025, ahead-of-print: 1-8. PMID: 40047379, DOI: 10.1080/17512433.2025.2472837.Peer-Reviewed Original ResearchSmoking cessationE-cigarettesEvidence-based clinical guidelinesEfficacy of e-cigarettesBenefits of e-cigarettesSmoking cessation treatmentHarm reduction optionsHarm reduction principlesNicotine replacement therapyNicotine e-cigarettesQuality of lifeIncreased life expectancyNicotine useCessation treatmentClinical guidelinesNicotineSmokingLife expectancyCigarette smokingClinical pharmacology perspectivePharmacological perspectiveClinical practiceHigh riskLong-term effectsReplacement therapyA biomarker framework for auditory system aging: the Aging Biomarker Consortium consensus statement
Consortium A, Fu X, Wang S, Wu Y, Sun Y, Liu W, Xi X, Li G, Liu K, Yuan W, Chen F, Wang H, Yang T, Liu Y, Zheng J, Shi H, Qu J, Chen X, Suo L, Huang Y, Xu X, Tang X, Li X, Xu L, Gao X, Yu L, Shu Y, Zhang W, Sun J, Yuan H, Gong S, Li W, Ma X, Zha D, Gao J, Li H, He Z, Liu G, Pei G, Kong W, Wang H, Chai R. A biomarker framework for auditory system aging: the Aging Biomarker Consortium consensus statement. Life Medicine 2025, lnaf011. DOI: 10.1093/lifemedi/lnaf011.Peer-Reviewed Original ResearchAuditory healthAuditory systemAssociated with cognitive declineQuality of lifeHearing lossOlder adultsPsychosocial disordersSensory impairmentElderly populationConsensus statementCognitive declineHearingHealthAging societyVerbal communicationAgeSensory functionAbstract HearingHumoral biomarkersBiomarkers ConsortiumBiomarkersInterventionAging biomarkersAdultsComprehensive evaluationA plain language summary of the ASCERTAIN trial: oral decitabine and cedazuridine versus intravenous decitabine for MDS or CMML
Garcia-Manero G, McCloskey J, Griffiths E, Yee K, Zeidan A, Al-Kali A, Deeg H, Sabloff M, Keating M, Zhu N, Gabrail N, Fazal S, Maly J, Odenike O, DeZern A, O'Connell C, Roboz G, Busque L, Buckstein R, Amin H, Leber B, Shastri A, Oganesian A, Keer H, Azab M, Savona M. A plain language summary of the ASCERTAIN trial: oral decitabine and cedazuridine versus intravenous decitabine for MDS or CMML. Future Oncology 2025, 21: 929-941. PMID: 40051275, PMCID: PMC11938952, DOI: 10.1080/14796694.2025.2468578.Peer-Reviewed Original ResearchChronic myelomonocytic leukemiaAcute myeloid leukemiaIntravenous decitabineMyelodysplastic syndromeDEC-COral decitabineSide effectsRed blood cell transfusionPhase 3 clinical trialsMedian overall survivalTreatment-related deathsBlood cell transfusionDays of treatmentTransfusion independenceOverall survivalCell transfusionDecitabine groupMyelomonocytic leukemiaMyeloid leukemiaOral medicineDecitabineQuality of lifeReceiving treatmentTaking treatmentCedazuridineProtocol for the economic evaluation of group interpersonal therapy for postnatal depression compared with high-quality standard care in Kenya and Lebanon (SUMMIT trial)
Jaoude G, Madeghe B, Maradian S, Posbic P, Machoka J, Ndamaiyu G, Simes E, O’Donnell C, Wallace-Hanlon S, Evans R, Fearon P, Allison E, Pilling S, Verdeli L, Cheng B, Fouad F, Ngunu C, Chammay R, Kumar M, Fonagy P, Skordis J. Protocol for the economic evaluation of group interpersonal therapy for postnatal depression compared with high-quality standard care in Kenya and Lebanon (SUMMIT trial). NIHR Open Research 2025, 5: 17. DOI: 10.3310/nihropenres.13838.1.Peer-Reviewed Original ResearchInterpersonal therapyIncremental cost-effectiveness ratioChildren's cognitive developmentCognitive developmentPostnatal depressionEconomic evaluationUniversity College London Research Ethics CommitteeStandard careEstimate incremental cost-effectiveness ratiosLong-term depressionTrial outcomesPoor developmental outcomesPrimary trial outcomeDepression outcomesSecondary trial outcomesMaternal depressionPeer-reviewed journal publicationsControlled superiority trialImprove children's cognitive developmentResearch Ethics CommitteeKenyatta National HospitalQuality of lifeCost-effectiveness ratioIntention-to-treat analysisTrial follow-upLong-Term Air Pollution Exposure and Severity of Idiopathic Pulmonary Fibrosis: Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry.
Sack C, Wojdyla D, MacMurdo M, Gassett A, Kaufman J, Raghu G, Redlich C, Li P, Olson A, Leonard T, Todd J, Neely M, Snyder L, Gulati M, Baker A, Beegle S, Belperio J, Condos R, Cordova F, Southern B, Dilling D, Fitzgerald J, Flaherty K, Gibson K, Gulati M, Guntupalli K, Gupta N, Case A, Hotchkin D, Huie T, Kaner R, Kim H, Lancaster L, Lasky J, Lee D, Liesching T, Lipchik R, Lobo J, Luckhardt T, Mageto Y, Kokoszynska M, Morrison L, Namen A, Oldham J, Paul T, Zhang D, Porteous M, Raj R, Ramaswamy M, Russell T, Sachs P, Safdar Z, Shafazand S, Siddiqi A, Fowler R, Strek M, Rivas-Perez H, Tabak J, Walia R, Whelan T. Long-Term Air Pollution Exposure and Severity of Idiopathic Pulmonary Fibrosis: Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry. Annals Of The American Thoracic Society 2025, 22: 378-386. PMID: 39531618, DOI: 10.1513/annalsats.202404-382oc.Peer-Reviewed Original ResearchAssociated with worse qualityExposure to air pollutionGene-environment interactionsQuality of lifePollution exposureEffects of long-term exposure to air pollutionLong-term exposure to PM<sub>2.5</sub> anLong-term exposure to air pollutionWorse qualityParticipant's residential addressQuality of life measuresNon-Hispanic whitesExposure to PM<sub>2.5</sub>Multi-pollutant modelsYears of follow-upCox proportional hazards modelsLower FVC %Residential addressesProportional hazards modelIPF-PRO RegistryMultivariate regression modelEffect modificationEuroQol scoresLife measuresEnrollment dateResearch Priorities in Neuropalliative Care
Lau W, Fehnel C, Macchi Z, Mehta A, Auffret M, Bogetz J, Fleisher J, Graber J, Leeper H, Manglani-Terranova H, Muehlschlegel S, Mroz E, Pedowitz E, Ramanathan U, Sarmet M, Shlobin N, Sokol L, Weeks S, Xu J, Medsger H, Creutzfeldt C, Vranceanu A, Zahuranec D, Hwang D. Research Priorities in Neuropalliative Care. JAMA Neurology 2025, 82: 295-302. PMID: 39899319, DOI: 10.1001/jamaneurol.2024.4932.Peer-Reviewed Original ResearchConceptsNeuropalliative careCare partnersIntegration of palliative careSpecialty palliative care servicesGoal-concordant carePalliative care servicesInterdisciplinary panel of expertsArea of practiceImprove quality of lifeQuality of lifePalliative careCare interventionsCare servicesPanel of expertsDelivery modelsPriority research areasCareInterdisciplinary panelImprove qualityCare SocietyResearch prioritiesResearch funding mechanismsResearch CommitteeSpecialized communicationNeurological diseasesEliglustat substrate reduction therapy in children with Gaucher disease type 1
Ain N, Saith A, Ruan A, Yang R, Burton A, Mistry P. Eliglustat substrate reduction therapy in children with Gaucher disease type 1. Frontiers In Pediatrics 2025, 13: 1543136. PMID: 40083427, PMCID: PMC11903696, DOI: 10.3389/fped.2025.1543136.Peer-Reviewed Original ResearchEnzyme replacement therapySubstrate reduction therapyGD1 patientsPediatric patientsReduction therapyOral substrate reduction therapyPrimary outcomeAlternative to enzyme replacement therapyIntravenous enzyme replacement therapyLevels compared to baselineGaucher disease type 1Indicator of disease activityParent-reported qualityCYP2D6 metabolizer statusRare lysosomal storage disorderProspective case seriesGaucher diseaseType 1 Gaucher diseaseQuality of lifeDisease indicationsLysosomal storage disorderPROMIS questionnairesReplacement therapyCase seriesClinical benefitMapping the Ulcerative Colitis Patient Journey in Saudi Arabia from Healthcare Professionals’ Perspective: A Cross-Sectional Non-Interventional Study
Azzam N, Mosli M, Almutairdi A, Alghamdi M, Meeralam Y, Alolimi K, Arsalan M, Al-Bawardy B. Mapping the Ulcerative Colitis Patient Journey in Saudi Arabia from Healthcare Professionals’ Perspective: A Cross-Sectional Non-Interventional Study. Journal Of Clinical Medicine 2025, 14: 1621. PMID: 40095549, PMCID: PMC11899997, DOI: 10.3390/jcm14051621.Peer-Reviewed Original ResearchComputer-assisted personal interviewsQuality of lifeGeneral practitionersPatient journeyTreatment goalsHealthcare professionals' perspectivesTNF-a inhibitorsInternal medicine physiciansBurden of ulcerative colitisUlcerative colitisClinical remissionImprovement of quality of lifeUC patientsOral systemic steroidsHealthcare professionalsSaudi ArabiaTNF-aPhysician responsesSurvey domainsYears of experienceProfessional perspectivesQuantitative interviewsTreating gastroenterologistImprove accessMedicine physiciansThe neural characteristics influencing literacy outcome in children with cochlear implants
Koirala N, Manning J, Neumann S, Anderson C, Deroche M, Wolfe J, Pugh K, Landi N, Muthuraman M, Gracco V. The neural characteristics influencing literacy outcome in children with cochlear implants. Brain Communications 2025, 7: fcaf086. PMID: 40046341, PMCID: PMC11881800, DOI: 10.1093/braincomms/fcaf086.Peer-Reviewed Original ResearchCochlear implantationHearing interventionDuration of deafnessCongenital hearing lossQuality of lifeHearing aidsHearing ageHearing lossImpact of early auditory deprivationAuditory deprivationAuditory developmentFunctional near-infrared spectroscopyTiming of interventionClinical measuresEarly auditory deprivationInterventionEarly interventionAdequate accessHearingReading outcomesReading abilityNeural characteristicsEnhanced outcomesInitial implantationNeural reorganizationFunctional Outcomes for Patients With Congenital Anorectal Malformations: A Systematic Review and Evidence-based Guideline From the APSA Outcomes and Evidence Based Practice Committee
Rialon K, Smith C, Rentea R, Acker S, Baird R, Beres A, Chang H, Christison-Lagay E, Diesen D, Englum B, Gonzalez K, Gulack B, Ham P, Huerta C, Kulaylat A, Levene T, Lucas D, Mansfield S, Pennell C, Ricca R, Sulkowski J, Tashiro J, Wakeman D, Yousef Y, Kelley-Quon L, Kawaguchi A, Committee A. Functional Outcomes for Patients With Congenital Anorectal Malformations: A Systematic Review and Evidence-based Guideline From the APSA Outcomes and Evidence Based Practice Committee. Journal Of Pediatric Surgery 2025, 60: 162243. PMID: 40023107, DOI: 10.1016/j.jpedsurg.2025.162243.Peer-Reviewed Original ResearchQuality of lifeSystematic reviewStructured care planFunctional outcomesAnorectal malformationsOptimal patient counselingComplex patient populationTransitional careLevel of evidenceCare planningImprove carePatient transitionsPsychosocial issuesAdult careAmerican Pediatric Surgical Association OutcomesPsychosocial functioningCareConstipation ratePractice CommitteeAnorectal malformation patientsAssociated outcomesCongenital anorectal malformationsMulti-institutional registryPatient counselingLong-term outcomesUse, Benefits, and Barriers to Financial and Credit Counseling Among Veterans According to Financial Counselors and Other Subject Matter Experts
Kinney R, Hooshyar D, Tsai J. Use, Benefits, and Barriers to Financial and Credit Counseling Among Veterans According to Financial Counselors and Other Subject Matter Experts. Military Medicine 2025, usaf040. PMID: 39954081, DOI: 10.1093/milmed/usaf040.Peer-Reviewed Original ResearchVeterans AffairsLack of program awarenessLow-income veteransClose-ended responsesMoney management interventionSubject matter expertsFinancial counselingQuality of lifeOpen-ended responsesEconomic well-beingLocal VASource of incomeMatter expertsDescriptive statisticsProgram awarenessU.S. veteransRepresentative payeeVeteransManagement interventionsPoverty lineWell-beingFinancial providersEconomic resourcesTrust relationshipsPositive outcomesAlpha rhythm and Alzheimer’s disease: Has Hans Berger’s dream come true?
Babiloni C, Arakaki X, Baez S, Barry R, Benussi A, Blinowska K, Bonanni L, Borroni B, Bayard J, Bruno G, Cacciotti A, Carducci F, Carino J, Carpi M, Conte A, Cruzat J, D'Antonio F, Della Penna S, Del Percio C, De Sanctis P, Escudero J, Fabbrini G, Farina F, Fraga F, Fuhr P, Gschwandtner U, Güntekin B, Guo Y, Hajos M, Hallett M, Hampel H, Hanoğlu L, Haraldsen I, Hassan M, Hatlestad-Hall C, Horváth A, Ibanez A, Infarinato F, Jaramillo-Jimenez A, Jeong J, Jiang Y, Kamiński M, Koch G, Kumar S, Leodori G, Li G, Lizio R, Lopez S, Ferri R, Maestú F, Marra C, Marzetti L, McGeown W, Miraglia F, Moguilner S, Moretti D, Mushtaq F, Noce G, Nucci L, Ochoa J, Onorati P, Padovani A, Pappalettera C, Parra M, Pardini M, Pascual-Marqui R, Paulus W, Pizzella V, Prado P, Rauchs G, Ritter P, Salvatore M, Santamaria-García H, Schirner M, Soricelli A, Taylor J, Tankisi H, Tecchio F, Teipel S, Kodamullil A, Triggiani A, Valdes-Sosa M, Valdes-Sosa P, Vecchio F, Vossel K, Yao D, Yener G, Ziemann U, Kamondi A. Alpha rhythm and Alzheimer’s disease: Has Hans Berger’s dream come true? Clinical Neurophysiology 2025, 172: 33-50. PMID: 39978053, DOI: 10.1016/j.clinph.2025.02.256.Peer-Reviewed Original ResearchConceptsPathological agingAlzheimer's diseaseExpert panelAlpha rhythmAD patient’s qualityQuality of lifeAging-Alzheimer's AssociationCognitive impairmentCognitive declineClinical workupNeuroscience SocietyCortical circuitsAD patientsUS National InstitutesOlder adultsRoutine useSenile dementiaDecades of researchPatients' qualityClinical guidelinesOscillatory synchronizationCause of dementiaClinical applicationNIA-AADementiaThe impact of Duration of Untreated Psychosis on functioning and quality of life over one year of Coordinated Specialty Care (CSC)
Hazan H, Tayfur S, Zhou B, Li F, Gibbs-Dean T, Karmani S, Kline E, Ferrara M, Corbera S, Riley S, Sykes L, Tek C, Keshavan M, Srihari V. The impact of Duration of Untreated Psychosis on functioning and quality of life over one year of Coordinated Specialty Care (CSC). PLOS ONE 2025, 20: e0312740. PMID: 39928579, PMCID: PMC11809850, DOI: 10.1371/journal.pone.0312740.Peer-Reviewed Original ResearchConceptsCoordinated specialty careQuality of lifeDuration of untreated psychosisDUP groupWorld Health OrganizationYear of coordinated specialty careGeneralized linear modelConfidence intervalsBinary outcomesGlobal functioningDuration of untreated psychosis groupSymptom severityUntreated psychosisSpecialty careCSC programsImpact of duration of untreated psychosisFunctional gainsModel repeated measuresMixed model repeated measuresOdds ratioNo significant differenceLogit link functionStatus improvementContinuous outcomesSocial functioningQuality of Life Outcomes With a Risk-Based Precision Testing Strategy Versus Usual Testing in Stable Patients With Suspected Coronary Disease: Results From the PRECISE Randomized Trial
Mark D, Li Y, Nanna M, Kelsey M, Daniels M, Rogers C, Patel M, Baloch K, Chow B, Anstrom K, Vemulapalli S, Weir-McCall J, Stone G, Chew D, Douglas P, Investigators O. Quality of Life Outcomes With a Risk-Based Precision Testing Strategy Versus Usual Testing in Stable Patients With Suspected Coronary Disease: Results From the PRECISE Randomized Trial. Circulation Cardiovascular Quality And Outcomes 2025, 18: e011414. PMID: 39895494, PMCID: PMC11837958, DOI: 10.1161/circoutcomes.124.011414.Peer-Reviewed Original ResearchConceptsQuality of lifeSAQ Summary ScoreSummary scoreOveral quality of lifeAssess quality of lifeGeneric health statusQuality of life outcomesBaseline SAQ scoresCoronary artery diseaseQuality of life assessmentFollow-up time pointsClinically meaningful differencesStable patientsFollow-upArtery diseaseEQ-5DHealth statusMonths postrandomizationSuspected coronary diseaseComponent scoresSatisfaction surveySuspected coronary artery diseaseTrial participantsStable chest painTest groupPain Coping Skills Training for Patients Receiving Hemodialysis
Dember L, Hsu J, Mehrotra R, Cavanaugh K, Kalim S, Charytan D, Fischer M, Jhamb M, Johansen K, Becker W, Pellegrino B, Eneanya N, Schrauben S, Pun P, Unruh M, Morasco B, Mehta M, Miyawaki N, Penfield J, Bernardo L, Brintz C, Cheatle M, Doorenbos A, Heapy A, Keefe F, Krebs E, Kuzla N, Nigwekar S, Schmidt R, Steel J, Wetmore J, White D, Kimmel P, Cukor D, Adams M, Almonte-Then S, Amonu C, Anderson L, Argega Leon A, Argyropoulos C, Ashley E, Bajana Meza M, Bansal N, Barbosa M, Barrell T, Bart G, Barton A, Beach S, Beeks L, Belcher J, Berman N, Berry D, Bhatraju E, Bishop N, Blazes C, Busch A, Cameron S, Cardona M, Casilli V, Cazes M, Chacon Palma G, Chalamidas K, Chaudry S, Chen N, Chicos I, Clark C, Collins D, Connelly L, Contreras B, Cosmin A, Crowley S, Dalton C, Dirks J, Donahue S, Dutka P, Dyer V, Edeh O, Edwards D, Edwards D, Ekor K, Esserman D, Falker C, Farkas L, Farrar J, Felson S, Flores Y, Fraticelli Ortiz D, Garcia G, Gear L, Geibel A, Gilmartin C, Goldfarb D, Goldfeld K, Goldstein A, Gong A, Grant C, Grindstaff R, Guajardo E, Guy C, Hamm M, Hammond J, Harris K, Hoffman S, Holden C, Howell H, Ikizler T, Joffe S, Joffe J, Johnson S, Kalam E, Kampman K, Keane C, Kimura G, Kirsch O, Kourany W, Krishnamurthy P, Kubrick P, Lacey P, Landis J, Lash J, Lazlo K, Lee J, Lefler J, Leon Cupe A, Lerner S, Liebschutz J, Lietz P, Linke L, Lockwood M, Luo H, Macina A, McCarthy A, McDaniels K, McLaren S, McNeil D, Meinel M, Mejia V, Mengesha B, Merriman D, Michael W, Mims R, Mishra P, Modersitzki F, Moss A, Mullins C, Munet U, O'Connell K, Okereke U, Olejniczak D, Opeke S, Pacheco-Hernandez M, Pankratz S, Park D, Payne K, Pegues H, Percy S, Pleasant S, Purdy T, Quinn D, Quintana N, Rice K, Robinson G, Roche C, Rodriguez Sosa G, Rudow G, Rudy Q, Rutledge J, Sanchez S, Sands B, Scherer J, Schopp M, Self B, Shallcross A, Silva K, Stallings T, Stauffer C, Steffen A, Stewart T, Stringfellow S, Sullivan L, Torres R, Torres J, Trejo G, Varela D, Vassilieva S, Vilchis H, Villareal D, Walsh J, Ways J, Weidner T, Weimer M, Weiner D, Weisbord S, Wilkie C, Wilkinson M, Williams S, Williams J, Wilson O, Wood V, Yabes J, Zamora G, Zaniga S. Pain Coping Skills Training for Patients Receiving Hemodialysis. JAMA Internal Medicine 2025, 185: 197-207. PMID: 39786400, PMCID: PMC11791705, DOI: 10.1001/jamainternmed.2024.7140.Peer-Reviewed Original ResearchConceptsPain coping skills trainingPain coping skills training groupUsual care groupBrief Pain InventoryUsual carePain interferenceCoping skills trainingCare groupQuality of lifePain catastrophizingPain intensityBPI interferenceOutcomes of pain intensityRandomized clinical trialsSecondary outcomesChronic painSecondary outcomes of pain intensitySkills trainingBPI interference scoreCognitive behavioral interventionProportion of participantsOutpatient dialysis facilitiesClinically meaningful improvementsPain interventionsRandomized clinical trial of patientsCare Models to Improve Pain and Reduce Opioids Among Patients Prescribed Long-Term Opioid Therapy
Krebs E, Becker W, Nelson D, DeRonne B, Jensen A, Kats A, Morasco B, Frank J, Makris U, Allen K, Naylor J, Mixon A, Bohnert A, Reznik T, Painter J, Hudson T, Hagedorn H, Manuel J, Borsari B, Purcell N, Hammett P, Amundson E, Kerns R, Barbosa M, Garvey C, Jones E, Noh M, Okere J, Bhushan S, Pinsonnault J, Williams B, Herbst E, Lagisetty P, Librodo S, Mapara P, Son E, Tat C, Marraffa R, Seys R, Baxley C, Seal K, Abelleira A, Adams M, Anicich A, Ankawi B, Arnold S, Aryal A, Atkins D, Atkinson T, Backe K, Bair M, Bajpai S, Baller K, Bangerter A, Barnett S, Bartlett S, Bartnik M, Baskin J, Blehm R, Bloechl P, Boening N, Boesch N, Bolander S, Bolf M, Bonchak J, Booth K, Bordanea M, Borowa D, Bowden M, Britnell S, Broderick D, Bronars C, Brooks K, Brown C, Brudvik E, Buchanan K, Buesgens C, Buonora M, Burch R, Burton C, Butler C, Byerly S, Byrd C, Byrd G, Campbell E, Cariveau D, Carmody S, Carr M, Carr T, Cervone D, Chandler M, Clarke K, Clay M, Coy W, Craine M, Culver D, Cutting A, Dadabayev A, Daly D, Degerstrom R, Denietolis A, DePesa N, Desmet P, Devlin A, Dike D, Diokpa C, Dogra M, Drexler K, Drum-Oden A, Duvall T, Eads F, Edmond S, Eichelsdoerfer E, Ellifritz C, Ellison J, Erwin K, Escobedo C, Feighner L, Feuchs A, Fike A, Finetti T, Franchina L, Freeman J, Frontera R, Galvan R, Gayle S, Givens C, Glenn R, Godwin K, Goldstein M, Gosselin K, Graham S, Grimm K, Gumidyala A, Hagerman C, Hale A, Hall L, Harden J, Hawkins J, Hepton S, Herynk A, Heuermann B, Hidalgo N, Hoffmann J, Holland-deguire C, Hope K, Horowitz D, Huang A, Huffman K, Hunt N, Hyde S, Jacobson K, Johnson E, Kaiser B, Kauzlarich K, Kavathekar R, Knutson R, Kross T, LaHaie E, Lahidji S, Le G, Lelovic M, Lewis M, Linden E, Lindsay D, Lively-Brindley L, Lorenzo J, Luciani L, Lusk C, Mahal-Lichty J, Maloy P, Marcolivio K, Marcy B, Marek L, Mason B, McCamish N, McKissack M, Miller E, Moon J, Morris H, Mundt J, Nazario M, Nelson A, Nichols A, Njau E, Nolan C, Nolan P, Nugent S, Oakley J, Ofstad H, Olney R, Olson J, Ortolan V, Osborne J, Osler B, Packard-Milam M, Palyo S, Patel A, Wiener C, Peter D, Philippe M, Reddy S, Reed J, Rettmann N, Rezaei D, Roberti A, Robinson V, Roca H, Romano E, Rosema T, Rouse R, Rozzero P, Rutks I, Sabet R, Sacra E, Sadowski N, Salameh H, Sandbrink F, Sauve C, Schopmeyer K, Schroeder A, Sculley M, Sellinger J, Sewell K, Shah Barman M, Sharpe P, Sides T, Silver K, Siver M, Sloan J, Smith C, Stevens S, Stoll J, Stoll S, Stoner T, Strand M, Sumner J, Surginer B, Svabek K, Swanson G, Tappainer C, Taylor B, Theis A, Thomas L, Thomas G, Tiene K, Udouj R, Ugbo E, Varughese S, Venkatraman S, Viera K, Walker J, Walker J, Wang G, Watson K, Watson E, Westmoreland W, Wilbur E, Wolfman A, Woloszyn M, Zanga J, Zuniga S. Care Models to Improve Pain and Reduce Opioids Among Patients Prescribed Long-Term Opioid Therapy. JAMA Internal Medicine 2025, 185: 208-220. PMID: 39652356, PMCID: PMC11791716, DOI: 10.1001/jamainternmed.2024.6683.Peer-Reviewed Original ResearchIntegrated Pain TeamLong-term opioid therapyPatients prescribed long-term opioid therapyVeterans Affairs primary care clinicsOpioid therapyPrescribed long-term opioid therapyRandomized comparative effectiveness trialPharmacist care managementCollaborative care interventionPain care planPrimary care clinicsPoor quality of lifeMental health cliniciansOpioid dosageComparative effectiveness trialPain responseDaily dosageModerate to severe chronic painQuality of lifePain careCare modelCare planningCare interventionsCare clinicsOpioid dose reduction
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply